- Home
- DXCM vs SSNC Comparison
DXCM vs SSNC Comparison
Compare DXCM & SSNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DXCM | SSNC |
|---|---|---|
| Founded | 1999 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 21.7B |
| IPO Year | 2005 | 1996 |
Fundamental Metrics
Financial Performance| Metric | DXCM | SSNC |
|---|---|---|
| Price | $69.83 | $85.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 22 | 9 |
| Target Price | $86.41 | ★ $101.11 |
| AVG Volume (30 Days) | ★ 4.8M | 1.2M |
| Earning Date | 02-12-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 1.26% |
| EPS Growth | 7.75 | ★ 20.69 |
| EPS | 1.80 | ★ 3.37 |
| Revenue | $4,515,900,000.00 | ★ $6,148,400,000.00 |
| Revenue This Year | $17.41 | $8.28 |
| Revenue Next Year | $12.73 | $5.86 |
| P/E Ratio | $38.70 | ★ $25.46 |
| Revenue Growth | ★ 14.21 | 6.67 |
| 52 Week Low | $54.11 | $69.61 |
| 52 Week High | $93.25 | $91.07 |
Technical Indicators
Market Signals| Indicator | DXCM | SSNC |
|---|---|---|
| Relative Strength Index (RSI) | 58.89 | 44.24 |
| Support Level | $65.60 | $84.49 |
| Resistance Level | $71.28 | $86.64 |
| Average True Range (ATR) | 2.27 | 1.72 |
| MACD | 0.05 | -0.39 |
| Stochastic Oscillator | 64.43 | 21.97 |
Price Performance
Historical ComparisonAbout DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About SSNC SS&C Technologies Holdings Inc.
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.